Swedish Orphan Biovitrum AB (OTCPK:BIOVF)
$ 31.38 -0.63 (-1.97%) Market Cap: 10.45 Bil Enterprise Value: 12.07 Bil PE Ratio: 31.90 PB Ratio: 3.01 GF Score: 90/100

Q2 2023 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript

Jul 18, 2023 / 11:00AM GMT
Release Date Price: $20.27 (+4.24%)
Operator

Ladies and gentlemen, welcome to the Q2 2023 Report Conference Call and Live Webcast. I am Alis, the Chorus Call operator. (Operator Instructions) At this time, it's my pleasure to hand over to Guido Oelkers, CEO. Please go ahead, sir.

Guido Oelkers;publ;CEO;President
Swedish Orphan Biovitrum AB

()-&

Yes. Thank you so much, and welcome, everybody. This is Guido Oelkers, CEO of Sobi. As you can see from the Q2 report that we published earlier this morning, we're obviously super excited about the performance in 2023 so far and delighted to welcome you to the second quarter 2023 conference call for investors and analysts.

We posted this presentation on our website, sobi.com, and we would like to -- let's go to the next slide, the safe harbor statement as per usual.

We would like to remind you of the usual provisions unless I stated otherwise, we will make comments that most relates to second quarter performance and 2023 at constant exchange rate in million Swedish krona.

Today, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot